InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,246.40
(
0.37%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.95
(
0.91%
)
Bitcoin
61,394.56
(
-0.67%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: adreamer post# 20582

Thursday, 07/19/2012 9:12:05 AM

Thursday, July 19, 2012 9:12:05 AM

Post# of 80490
ARIAD price target raised to $23 from $20 at RBC Capital
RBC Capital increased its target on ARIAD as the firm believes that the potential opportunities of the company's '113 drug for ALK mutations will become clearer over the next 6-12 months. The firm maintains an Outperform rating on the stock.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up